A new research paper was published in Volume 16 of Oncotarget on October 13, 2025, titled “Treatment of glioblastoma with ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick ...

Working with an international team of collaborators, scientists at Columbia University have found a way to shift the balance ...

Libtayo is approved for adjuvant treatment in high-risk CSCC patients post-surgery and radiation, showing significant disease-free survival benefits in the C-POST trial. The C-POST trial excluded ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist ...

Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study This retrospective cohort study identified adults in ...

Skin cancer is the most common type of cancer in the United States with 5.4 million new cases of the disease reported every year. TODAY contributor and New Beauty editor-at-large Sarah Eggenberger ...